Chunming WANG

Chunming (‘CM’) WANG       王春明
Associate Professor
Programme Director (Teaching / Research), Institute of Chinese Medical Sciences (ICMS)

Academic Qualifications

  • PhD                  Nanyang Technological University (Singapore)
  • MSc                 Nanjing University (China)
  • BSc                  Nanjing University (China)


Undergraduate modules

  • BIOB210          General Microbiology
  • BIOB211          General Microbiology – Laboratory

Graduate modules

  • CMED718        Pharmaceutical Science
  • CMED721        Emerging Materials in Clinical Medicine
  • CMED812        Pharmaceutical Engineering & Biomaterials Science
  • GRSC802         Research Writing


Cells and tissue microenvironment are like seeds and soil; the ‘soil’ supports the ‘seeds’ to grow, while the ‘seeds’ remodel the ‘soil’ through secretion. We aim to optimise the soil and thereby improve the seeds’ growth by targeting macrophages, which play central roles in wound healing and tissue repair. We design biomaterials tools and cell-based strategies to modulate macrophages’ phenotypes (e.g. via TLR-carbohydrate interaction), stabilise their secreted molecules (e.g. via growth factors-GAG interaction) and more generally create a pro-regenerative niche (e.g. by ‘utilising’ specifically induced macrophages). We are testing our concepts and designs with various models ranging from bone defects to dental implants to diabetic skin ulcers.

Dr Chunming Wang (CM) received his Bachelor and Master’s degrees in Biochemistry from Nanjing University (China), entering the field of biomaterials research under the supervision of Junfeng Zhang. He obtained his PhD in Biomedical Engineering from Nanyang Technological University (Singapore) under the supervision of Dong-An Wang. Then, CM undertook his postdoctoral training at the University of Cambridge (UK), working between Wilhelm Huck’s group in the Chemistry Department and Fiona Watt’s lab at the Wellcome Trust Centre for Stem Cell Research, before returning to Singapore to join the Institute of Medical Biology, Agency for Science, Technology and Research (A*STAR), where he assisted Simon Cool and Victor Nurcombe in collaboration with industry on a cross-institutional drug discovery project.

In Oct 2012, CM took the Assistant Professorship at ICMS, University of Macau, to continue his scientific exploration in developing bio-inspired materials for a wide range of medical applications. To date, he has won 10 research grants from O Fundo para o Desenvolvimento das Ciências e da Tecnologia de Macau (FDCT), National Natural Science Foundation of China (NSFC), University of Macau Research Committee as well as Nanjing University, China. These generous supports enabled the formation of ‘Chun Ming Tong Sui’ (春明糖水), a young and vibrant team devoted to weaving sweet polymer chains into new medicines. CMTS are also fortunate to have fantastic collaborators in Nanjing, Boston, Singapore and across Europe.

The team effort of CMTS has enabled CM to see himself twice among the winners of the Natural Science Award at the Macao Science and Technology Awards – 2nd and 3rd Prize in 2016 and 2018, respectively.

Now, we invite you to join us, visit us and support us to invent SWEET recipes for our SOUR body!

CMTS TeamCMTS Alumni
  • Principal Investigator
    • Dr Chunming ‘CM’ Wang (PI 2012.10-)


  • Staff
    • Mr Zhe Zhang (Research Assistant 2019.01-)


  • Students
    • Mr Yiming Niu (MS 2012.10-2014.07; PhD candidate 2014.08- )
    • Ms Yanxian Feng (PhD Candidate 2015.01-)
    • Mr Panfei Xing (PhD Candidate 2016.08-)
    • Ms Ruoyu Mu (PhD Candidate 2018.08-)
    • Mr Zhe Zhang (MSc Candidate 2016.08-)
    • Ms Yuhan Zhang (MSc Candidate 2017.08-)
    • Ms Huiqun Zhou (MSc Candidate 2018.08-)
    • Ms Xiaoyu Yin (MSc Candidate 2018.08-)
  • Visiting scientist
    • Dr Wei He (2016.09-.12; now an Associate Professor at Anhui Medical University, China)
    • Mr Richard Surgenor (2015.07-09; now a PhD student at University of Oxford, UK)
    • Prof Lei Dong (2013.07-.10; from Nanjing University, China)
  • Staff
    • Dr Lintao Wang (Research Associate 2017.09-2018.09; now a Lecturer at Nanjing University, China)
    • Ms Hongyan Long (RA 2016.05-2017.04; now a PhD candidate at Max Planck Institute, Germany)
    • Dr Helena Wang (Postdoc 2015.01-.06; now a scientist in biotech industry, Canada)
    • Ms Bertha Wong (RA 2014.07-2015.07; now at Centro Hospitalar Conde de São Januário, Macau)
  • Students
    • Mr Qiu Li (PhD Candidate 2013.09-2017.12; RA 2018.01-2018.06; now a Professor at Qingdao Agricultural University, China)
    • Ms Sunny Y Shi (MSc Candidate 2015.08-2018.01; now a Scientist at a pharma company in Hangzhou, China)
    • Mr Carlos Zhang (MSc 2014.08-2017.01, now at Sichuan Primed Bio-tech Group Co Ltd, Chengdu)
    • Mr Yu Wang (MSc 2013.09-2016.01; now a scientist in pharma industry, Shandong)
    • Ms Xiudan Zhan (MSc 2012.10-2015.01; now an entrepreneur, Guangzhou)
    • Mr Stanley Chan (Summer intern, 2013.05-08; now at University College London, UK)
    • Ms Winnie Chan (FYP 2014.06-2015.06; RA 2015.10-2016.04; now at Kiang Wu Hospital, Macau)
    • Ms Mathilda Cheang (FYP, 2015.01-05; now at University of Macau, Macau)


CMTS 2017 CMTS 2015 Award to the team
 (From left) Yanxian, Panfei, CM, Yiming, Hongyan, Qiu, Sunny (front), Zhe (back), Zebang

Photo courtesy © Communication Office University of Macau

(Back) Carlos, Qiu, CM, Yiming, Yu

(Front) Winnie, Bertha, Yanxian, Xiudan, Mathilda

Thanks to the team, CM was among the recipients of the 2016 Macao Science and Technology Award (2nd Prize).


Biomaterials ScaffoldsShoulder of GiantsCarlos’s Ocean Park Science-inspired Art
Sunny (front) & Carlos test injectable, in situ forming hydrogel scaffolds in mice at ICMS.Every year, CM tells the legendary story of Barry Marshall and Robin Warren (Nobel laureates 2005) in discovering H. pylori to his class. In 2016, CM finally meets Prof J Robin Warren in Singapore!Upon hearing that our paper published in Biomaterials Science was featured on the cover, Carlos surprised us by showing (off) his talent in art to the editorial office.CM’s painting, The Meuse River, inspired by his research visits to Prof Wilhelm Huck and several other biomaterials scientists in the Netherlands during the summer of 2015.

Selected Publications

Journal articles (in total ~80; h-index 24)

* (co-)corresponding author;  # co-first author

  1. YX Feng, RY Mu, ZZ Wang, PF Xing, JF Zhang, L Dong, CM Wang *. A toll-like receptor agonist mimicking microbial signals to generate tumor-suppressive macrophages. Nature Communications, in press;
  2. ZZ Wang, XY Rui, JN Qiu, YQ Yan, JJ Gan, S Liu, LT Wang, JF Zhang, CM Wang *, L Dong. Growing trans-species islets in tumor extract-remodeled testicles. Advanced Science, in press;
  3. YC Shi, LT Wang, YM Niu, N Yu, PF Xing, L Dong, CM Wang *. Fungal component coating enhances titanium implant-bone integration. Advanced Functional Materials, 2018, 28: 1804483;
    ~ Featured: Cover Story
  4. PF Xing, Z Zhang, YM Niu, YN Qi, L Dong, CM Wang *. Water solubility is essential for fluorescent probes to image hypochlorous acid in live cells. Chemical Communication, 2018,54, 9889-9892
    ~ Featured: Cover Story
  5. JJ Gan, YY Dou, YR Li, ZZ Wang, LT Wang, S Liu, Q Li, HR Yu, CY Liu, CW Han, Z Huang, JF Zhang, CM Wang *, L Dong. Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors. Biomaterials, 2018, 178: 95-108;
  6. YM Niu, Q Li, Y Ding, L Dong, CM Wang *. Engineered delivery strategies for enhanced control of growth factor activities in wound healing. Advanced Drug Delivery Reviews, in press;
  7. CM Wang, ZZ Wang, L Dong. Translating current bioanalytical techniques for studying corona activity. Trends in Biotechnology, 2018, 36: 661-672;
  8. PF Xing, YX Feng, YM Niu, Q Li, Z Zhang, L Dong, CM Wang *. A water-soluble, two-photon probe for imaging endogenous hypochlorous acid in live tissue. Chemistry – A European Journal, 2018, 22: 5748-53;
  9. ZZ Wang, CM Wang *, A Abudukeremu, X Rui, S Liu, XY Zhang, M Zhang, JF Zhang, L Dong. Engineering a Tumor Microenvironment-Mimetic Niche for Tissue Regeneration with Xenogeneic Cancer Cells. Advanced Science, 2018, 5: 1700666;
  10. Q Li, YM Niu, H Diao, LT Wang, XP Chen, YT Wang, L Dong, CM Wang *. In situ sequestration of endogenous PDGF-BB with an ECM-mimetic sponge for accelerated wound healing. Biomaterials, 2017, 148: 54-68;
  11. YM Niu, Q Li, RY Xie, S Liu, R Wang, PF Xing, YC Shi, YT Wang, L Dong, CM Wang *. Modulating the phenotype of host macrophages to enhance osteogenesis in MSC-laden hydrogels: design of a glucomannan coating material. Biomaterials, 2017, 139: 39-55;
  12. YX Feng, Q Li, D Wu, YM Niu, C Yang, L Dong, CM Wang *. A macrophage-activating, injectable hydrogel to sequester endogenous growth factors for in situ angiogenesis. Biomaterials, 2017, 134: 128-42;
  13. H Yin, F Dumur, YM Niu, MM Ayhan, O Grauby, W Liu, CM Wang, D Siri, R Rosas, A Tonetto, D Gigmes, R Wang, D Bardelang, O Ouari. Chameleonic dye adapts to various environments shinning on macrocycles of peptide and polysaccharide aggregates. ACS Applied Materials & Interfaces, 2017, 9: 33220-8;
  14. Y Wang, GX Guo, YX Feng, HY Long, DL Ma, CH Leung, L Dong, CM Wang *. A tumour microenvironment-responsive polymeric complex for targeted depletion of tumour-associated macrophages. Journal of Materials Chemistry B, 2017, 5: 7307-18;
    ~ Featured: Hot Paper 2017
  15. H Gao, X Liu, W Sun, N Kang, Y Liu, S Yang, QM Xu, CM Wang, XP Chen. Total tanshinones exhibits anti-inflammatory effects through blocking TLR-4 dimerisation via the MyD88 pathway. Cell Death & Disease, 2017, 8: e3004;
  16. H Gao, Y Cui, N Kang, X Liu, Y Liu, Y Zou, Z Zhang, X Li, S Yang, J Li, CM Wang, QM Xu, XP Chen. Isoacteoside, a dihydroxyphenylethyl glycoside, exhibits anti-inflammatory effects through blocking toll-like receptor 4dimerisation. British Journal of Pharmacology, 2017, 174: 2880-96;
  17. Q Li, YX Feng, W He, LT Wang, R Wang, L Dong, CM Wang *. Post-screening characterisation and in vivoevaluation of an anti-inflammatory polysaccharide fraction from EucommiaulmoidesCarbohydrate Polymers, 2017, 169: 304-14;
  18. W He #, CM Wang #, RY Mu, P Liang, Z Huang, JF Zhang, L Dong. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene, 2017, 36: 4212-23;
  19. ZZ Wang, CM Wang *, #, S Liu, W He, LT Wang, JJ Gan, Z Huang, ZH Wang, HY Wei, JF Zhang, L Dong. Specifically formed corona on silica nanoparticles enhances transforming growth factor-β1 activity in triggering lung fibrosis. ACS Nano, 2017, 11: 1659-72;
  20. WI Chan, GP Zhang, X Li, CH Leung, DL Ma, L Dong, CM Wang *. Carrageenan activates monocytes via type-specific binding with interleukin-8: an implication for design of immune-active biomaterials. Biomaterials Science, 2017, 5: 403-7;
    ~ Featured: Cover Story
  21. LT Wang, Q Chen, HX Qi, CM Wang, C Wang, JF Zhang and L Dong. Doxorubicin-induced systemic Inflammation is driven by upregulation of Toll-like receptor TLR4 and endotoxin leakage.
    Cancer Research, 2016, 76: 6631-42;
  22. Q Li, GX Guo, FC Meng, H Wang, YM Niu, QW Zhang, JF Zhang, YT Wang, L Dong, CM Wang *. A naturally-derived, growth factor-binding polysaccharide for therapeutic angiogenesis.
    ACS Macro Letters, 2016, 5: 617-21;
  23. XB Fang, YQ Xu, HF Chan, CM Wang, Q Zheng, F Xiao, MW Chen. A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma Therapy. Molecular Pharmaceutics, 2016, 13: 3613-25;
  24. Q Zhu, HX Qi, ZY Long, S Liu, Z Huang, JF Zhang, CM Wang *, L Dong. Extracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapy. Scientific Reports, 2016, 6: 28596;
  25. W He, P Liang, GX Guo, Z Huang, YM Niu, L Dong, CM Wang *, JF Zhang. Re-polarizing myeloid-derived suppressor cells (MDSCs) with cationic polymers for cancer immunotherapy.  Scientific Reports, 2016, 6: 24506;
  26. Z Huang, JJ Gan, ZY Long, GX Guo, XF Shi, CM Wang, YH Zang, Z Ding, JN Chen, JF Zhang, L Dong. Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection. Biomaterials, 2016, 90: 72-84;
  27. Y Niu, WI Chan, N Yu, JJ Gan, L Dong, CM Wang *. APTES-modified nanosilica – but neither APTES nor nanosilica – inhibits endothelial cell growth via arrest of cell cycle at G1 phase. Journal of Biomaterials Applications, 2015, 0885328215598497;
  28. Z Huang, JJ Gan, LX Jia, GX Guo, CM Wang, YH Zang, Z Ding, JN Chen, JF Zhang, L Dong. An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease. Biomaterials, 2015, 48: 26-36;
  29. ZP Zhang #, CM Wang #, YH Zha, W Hu, ZF Gao, YH Zang, JN Chen, JF Zhang, L Dong. Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy.
    ACS Nano, 2015, 9: 2405-19;
  30. JJ Liu, XD Zhan, JB Wan, YT Wang, CM Wang *. Review for carrageenan-based pharmaceutical biomaterials: Favourable physical features versus adverse biological effects. Carbohydrate Polymers, 2015, 121: 27-36;
  31. CM Wang, L Dong. Exploring ‘new’ bioactivities of polymers at the nano-bio interface. Trends in Biotechnology, 2015, 33: 10-14;
  32. XD Zhan, LX Jia, YM Niu, HX Qi, XP Chen, QW Zhang, JF Zhang, YT Wang, L Dong, CM Wang *. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Biomaterials, 2014, 35: 10046-57;
  33. Q Zhu, L Jia, ZF Gao, CM Wang, JF Zhang, L Dong. A Tumor Environment Responsive Doxorubicin-loaded Nanoparticle for Targeted Cancer Therapy. Molecular Pharmaceutics, 2014, 11: 3269-78;
  34. YM Niu, J Bai, RD Kamm, YT Wang, CM Wang *. Validating anti-metastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment. Molecular Pharmaceutics, 2014, 11: 2022-29;
  35. CM Wang, S Poon, S Murali, CY Koo, TJ Bell, SF Hinkley, HQ Yeong, K Bhakoo, V Nurcombe, SM Cool. Engineering a vascular endothelial growth factor-165-binding heparan sulfate for vascular therapy. Biomaterials, 2014, 35: 6776-86;
  36. JJ Liu, YT Wang, L Qiu, YY Yu, CM Wang *. Saponins of Panax notoginseng: chemistry, cellular Targets and therapeutic opportunities in cardiovascular diseases. Expert Opinion on Investigational Drugs, 2014, 23: 561-71;
  37. L Dong, CM Wang *. Harnessing the power of macrophages/monocytes for enhanced bone tissue engineering. Trends in Biotechnology, 2013, 31: 342-6;
  38. JE Gautrot, CM Wang, X Liu, SJ Goldie, B Trappmann, WTS Huck, FM Watt. Engineered micro-epidermis mimics normal tissue architecture and perturbation in cancer. Biomaterials, 2012, 33: 5221-9; 
  39. K Su, YH Gong, CM Wang, DA Wang. A novel shell-structure cell microcarrier (SSCM) for cell transplantation and bone regeneration medicine. Pharmaceutical Research, 2011, 28:1431-41;
    ~ Featured: Cover Story
  40. CM Wang, TT Lau, WL Loh, K Su, DA Wang. Cytocompatibility study of a natural biomaterial crosslinker – genipin with therapeutic model cells. Journal of Biomedical Materials Research: Part B, 2011, 97B: 58-65;
  41. CM Wang, RR Varshney, DA Wang. Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Advanced Drug Delivery Reviews, 2010, 62: 699-710;
    ~ Featured: Cover Story
  42. CM Wang, DA Wang. An injectable, nanoaggregate-based system for mesenchymal stem cell (MSC) delivery: enhancement of cell adhesion and prevention of cytotoxicity. Journal of Materials Chemistry, 2010, 20: 3166-70;
  43. CM Wang, GN Adrianus, N Sheng, SK Toh, YH Gong, DA Wang. In vitro performance of an injectable hydrogel / microsphere based immunocyte delivery system for localised anti-tumour activity. Biomaterials, 2009, 30: 6986-95;
  44. CM Wang, YH Gong, Y Zhong, YC Yao, K Su, DA Wang. The control of anchorage- dependent cell behavior within a hydrogel / microcarrier system in an osteogenic model. Biomaterials, 2009, 30: 2259-69;
  45. YC Yao #, CM Wang #(# co-first author), RR Varshney, DA Wang. Antisense makes sense in engineered regenerative medicine. Pharmaceutical Research, 2009, 26:263-75;
  46. YH Gong, CM Wang, RC Lai, K Su, F Zhang, DA Wang. A novel injectable polysaccharide hydrogel: modified gellan gum for long-term tissue regeneration in vitro. Journal of Materials Chemistry, 2009, 19: 1968 – 1977;
    ~ Featured: Cover Story of Journal of Materials Chemistry, Vol. 19, Issue 14, 2009;
    ~ Quoted: in “Application Highlights”, Chemical Technology, 6(2009), 3: T20.
  47. CM Wang, YH Gong, YM Lin, JB Shen, DA Wang. A novel gellan gel-based microcarrier for anchorage-dependent cell delivery. Acta Biomaterialia, 2008, 4: 1226-34;
  48. CM Wang, J Bai, YH Gong, F Zhang, JB Shen, DA Wang. Enhancing cell affinity of non-adhesive hydrogel substrate: the role of silica hybridization. Biotechnology Progress, 2008, 24: 1142-6;
    ~ Featured: Cover Image of Biotechnology Progress, Vol. 25.
  49. TT Jiang, JB Chang, CM Wang, Z Ding, JF Zhang, ET Kang. Adsorption of plasmid DNA onto poly 2-(dimethylamino) ethyl-methacrylate grafted PLLA for promotion of gene delivery. Biomacromolecules, 2007, 8: 1951-7;


  1. CM Wang, Q Li, Z Zhang, YT Wang. A new bioactive polysaccharide dressing for wound healing. Chinese Patent Application No. 201810172465.3;
  2. CM Wang, Q Li, YM Niu, YT Wang. An artificial tear hydrogel. Chinese Patent Application No. 2014105282269;
  3. JT Sun, JF Zhang, CM Wang, Yi Luo. An embolic liquid for aneurysm treatment. Chinese Patent. CN1634119.

Analysis & Editorial

  1. CM Wang, CK Lei, RB Wang, JB Xiao, YT Wang. Ten years of exploration, a new journey to start: advancing Chinese Medicineto the next level. Chinese Medicine, 2017, 12: 28;
  2. H Hu, YZ Shi, CM Wang. Contract research organisations (CROs) in China: Integrating Chinese research & development capabilities for global drug innovation. Globalization and Health, 2014, 10: 78.

Conference / symposium proceedings (presenting author is underlined)

  1. CM Wang. ‘Devising ‘Sweet’ Natural Tools for Therapeutic Applications’, 2nd International Symposium on Phytochemicals in Food and Medicine (2-ISPMF) & Annual Meeting of Phytochemical Society of Europe (PSE 2017), Fuzhou, China, 7th-10th Apr 2017; (Invited Lecture)
  2. Q Li, YM Niu, CM Wang. ‘Sequestering of PDGF-BB and FGF-2 with an acidic polysaccharide for in situ vascularization’, 4th Symposium on Innovative Polymers for Controlled Delivery (SIPCD) 2016, Suzhou, China, 24th-26th Sep 2016; (poster)
  3. CM Wang, YM Niu, GP Zhang, YX Feng. ‘Designing carbohydrate biomaterials to modulate macrophage behaviour for immunotherapy and tissue regeneration’, TERMIS-AP 2016, Tamsui, Taiwan, 03rd-06th Sep 2016; (oral presentation)
  4. YM Niu, Y Wang, GP Zhang, CM Wang. ‘Modulation of innate immune cells with polymer tools for therapeutic applications’, 2015 International Conference for Leading and Young Materials Scientists (IC-LYMS 2015), Sanya, China, 24th-27th Dec 2015; (oral presentation)
  5. YM Niu, CM Wang. ‘Macrophage-affinitive Glucomannan Biomaterials for Targeted Drug Delivery and Bone Tissue Regeneration’, 5th China-Europe Symposium on Biomaterials, Hangzhou, China, 8th-10th May 2015; (oral presentation)
  6. XD Zhan, YM Niu, CM Wang, ‘Glucomannan biomaterials targeting c-type lectins for drug delivery and tissue regeneration’, TERMIS-AP 2014, Daegu, Korea, 24th-27th Sep 2014; (oral presentation)
  7. CM Wang, S Poon, S Murali, CY Koo, TJ Bell, FS Hinkley, HQ Yeong, K Bhakoo, V Nurcombe, SM Cool. ‘Engineering a heparan sulphate for vascular therapy’, TERMIS-AP 2014, Daegu, Korea, 24th-27th Sep 2014; (poster)
      ~ Best poster award, TERMIS-AP 2014
  8. CM Wang, S Poon, S Murali, HQ Yeong, T Bell, S Hinkley, V Nurcombe, SM Cool, ‘Modulation of VEGF activity by heparan sulphate’, 8th International Conference on Proteoglycans, Frankfurt/Main, Germany, 25th-29th, Aug 2013; (oral presentation)
  9. CM Wang, XD Zhan, YM Niu, YT Wang, ‘A natural polysaccharide based drug delivery vehicle targeting tumour-associated macrophages for cancer immunotherapy’, 17th European Carbohydrate Symposium (Eurocarb 17), Tel-Aviv, Israel, 7th-11th Jul 2013; (oral presentation)
  10. CM Wang, JE Gautrot, B Trappmann, ‘Cell micro-patterning: a promising tool for cell biology study’, Cambridge Cancer Centre Postdoctoral Meeting, Cambridge, UK, 22 Oct 2010; (oral presentation)
  11. CM Wang, DA Wang, ‘Delivery of therapeutic cells in hydrogel composite free of apoptotic depletion’, ICCM-17 – 17th International Conference on Composite Materials, Edinburgh, UK, 27 – 31 Jul 2009; (oral presentation)
  12. CM Wang, DA Wang, ‘The control of anchorage-dependent cell behavior within a hydrogel / microcarrier system in an osteogenic model’, ICMAT 2009 – International Conference on Materials for Advanced Technologies, Singapore, 28 Jun 28 – 3 Jul 2009; (oral presentation)
  13. JT Sun, JF Zhang, CM Wang, ‘A Novel Liquid Embolic Material for Aneurysm Treatment’, 7th Endovascular Neurosurgery Conference of China, the Three Gorges, China, Aug, 2005. (oral presentation)

Academic Services & Honours

  • A biotechnology spin-off project ‘Golden Wound Dressing’ from our group and led by group member Mr, Zhe Zhang won
    • Gold Award; China’s Internet+ Innovation & Entrepreneurship 2017
    • First Prize; Bank of China Million Dollar Entrepreneurship Competition (Macau)
    • Excellence Award; HKUST Million Dollar Entrepreneurship Competition (National) 
  • 2nd Prize, Natural Science Award, 2016 Macao Science and Technology Award
    (awarded to YT Wang, SP Li, MY Lee, CH Leung and CM Wang)
  • Executive Editor, Chinese Medicine (BMC;  Impact Factor ® : 1.6)
  • Editorial Board, Biotechnology Letters (Springer; Impact Factor ® 2013: 1.6)
  • Outstanding Reviewer of 2015 of Biotechnology Letters
  • Outstanding Reviewer of 2010 of Pharmaceutical Research (official journal of the American Association of Pharmaceutical Scientists, AAPS)
  • Ad hoc journal referee for peer-reviewed academic journals:
ACS Applied Materials & Interfaces (2016 –)
Acta Biomaterialia (2017 –)
Advanced Drug Delivery Reviews (2010 – ) Biomaterials (2009 – )
Journal of Biomedical Materials Research (2008 – ) Journal of Cellular and Molecular Medicine (2008 – ) Pharmaceutical Research (2010 – )
Trends in Biotechnology (2015 – )
  • Young Scientist’s Referee (certified by Editor-in-chief, Prof David F Williams, 2009), Biomaterials
  • Trustee Committee Member, International Society for Chinese Medicine (ISCM)
  • Member and Chartered Chemist, RSC (Royal Society of Chemistry)
  • Member, TERMIS (Tissue Engineering & Regenerative Medicine International Society)
  • Representative of University of Macau at Global Young Scientists Summit 2016, Singapore

Contact Details

N22-6011, Institute of Chinese Medical Sciences,
University of Macau,
Avenida da Universidade,
Taipa, Macao SAR
Tel: +853 8822 4696
Fax: +853 2884 1358